FASN and metabolic dysfunction-associated steatotic liver disease: The results demonstrate that hepatic PLZF expression is dramatically increased in NAFLD mice in comparison to the control mice, where a significant elevation of lipogenic genes, including SREBP-1c and fatty acid synthase (FAS) was observed (Figures 1A–C).